Literature DB >> 9496902

Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line.

V L Bae1, C K Jackson-Cook, S J Maygarden, S R Plymate, J Chen, J L Ware.   

Abstract

BACKGROUND: The available human prostate cancer cell lines that are metastatic in athymic nude mice all have complex, highly aneuploid karyotypes. Other prostatic cells immortalized by transforming genes of SV40 or HPV and converted to tumorigenicity by additional genetic manipulation are not reported to be metastatic.
METHODS: Tumorigenic sublines of human prostate epithelial cells previously immortalized by transfection with the SV40T antigen gene were obtained by sequential passage in male athymic nude mice. These sublines were evaluated histopathologically for tumorigenicity and metastasis in athymic nude mice after subcutaneous, intraperitoneal, and intraprostatic injection. Each subline was characterized by standard (GTG-banding) cytogenetic and FISH analysis, and RNase protection assays for androgen receptor expression.
RESULTS: Two sublines produced metastases in lungs and the diaphragm of most mice after either intraprostatic or intraperitoneal injection. The M2205 subline formed large local tumors after intraprostatic injection. Cytogenetic aberrations present in the metastatic sublines, but not in the tumorigenic, nonmetastatic lines or the parental P69SV40T line, included dup(11)(q14q22), der(16) t (16;19) (q24;q13.1), which resulted in the loss of the short arm and proximal long arm of chromosome 19 (19q13.1-->19pter), and loss of the Y chromosome. None of the sublines expressed the androgen receptor.
CONCLUSIONS: These cytogenetically defined, SV40T-immortalized human prostate epithelial cell lines, with distinct biological behaviors in vivo, provide additional tools for the genetic analysis of the emergence of metastatic capacity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496902     DOI: 10.1002/(sici)1097-0045(19980301)34:4<275::aid-pros5>3.0.co;2-g

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  45 in total

Review 1.  Pharmacological approaches to defining the role of chaperones in aging and prostate cancer progression.

Authors:  Sarah A Harvey; Keith O Jensen; Lynne W Elmore; Shawn E Holt
Journal:  Cell Stress Chaperones       Date:  2002-04       Impact factor: 3.667

2.  PROTEOME-3D: an interactive bioinformatics tool for large-scale data exploration and knowledge discovery.

Authors:  Deborah H Lundgren; Jimmy Eng; Michael E Wright; David K Han
Journal:  Mol Cell Proteomics       Date:  2003-09-07       Impact factor: 5.911

3.  BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

Authors:  Jun Wei; John L Stebbins; Shinichi Kitada; Rupesh Dash; William Placzek; Michele F Rega; Bainan Wu; Jason Cellitti; Dayong Zhai; Li Yang; Russell Dahl; Paul B Fisher; John C Reed; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

4.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Authors:  Shihua Sun; Cynthia C T Sprenger; Robert L Vessella; Kathleen Haugk; Kathryn Soriano; Elahe A Mostaghel; Stephanie T Page; Ilsa M Coleman; Holly M Nguyen; Huiying Sun; Peter S Nelson; Stephen R Plymate
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

5.  Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.

Authors:  Hagit Schayek; Itay Bentov; Shihua Sun; Stephen R Plymate; Haim Werner
Journal:  Exp Cell Res       Date:  2010-03-23       Impact factor: 3.905

6.  Differentiation of prostate epithelial cell cultures by matrigel/ stromal cell glandular reconstruction.

Authors:  Shona H Lang; Joel Smith; Catherine Hyde; Catherine Macintosh; Michael Stower; Norman J Maitland
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Sep-Oct       Impact factor: 2.416

7.  IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis.

Authors:  Peng Fang; Vivian Hwa; Brian M Little; Ron G Rosenfeld
Journal:  Growth Horm IGF Res       Date:  2007-08-24       Impact factor: 2.372

8.  MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection.

Authors:  Xueping Zhang; Amy Ladd; Ema Dragoescu; William T Budd; Joy L Ware; Zendra E Zehner
Journal:  Clin Exp Metastasis       Date:  2009-09-22       Impact factor: 5.150

9.  Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers.

Authors:  Gennadi V Glinsky; Anja Krones-Herzig; Anna B Glinskii
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

10.  Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.

Authors:  Jennifer D Wu; Lily M Higgins; Alexander Steinle; David Cosman; Kathy Haugk; Stephen R Plymate
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.